Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/2000
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000005206A8 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
03/15/2000EP0984966A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity
03/15/2000EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0723453B1 Method of treating reproductive disorders
03/15/2000CN1247539A Process for preparing eprosartan
03/15/2000CN1247538A Process for preparing eprosartan
03/15/2000CN1247533A Heterocyclic carboxylic acid derivatives, prodn. and use thereof as endothelin receptor antagonists
03/15/2000CN1247472A Treatment of lupus nephritis with anti-CD40L compounds
03/15/2000CN1247088A Medicinal tea for invigorating function of kidnay and replenishing vital essence
03/15/2000CN1247085A Synergistic oral lithagogue liquid for urinary system
03/14/2000USRE36617 (Substituted aralkyl) heterocyclic compounds
03/14/2000US6037386 Latex barrier having polymer matrix comprising zinc oxide or zinc gluconate gel irritant deactivating agent; condoms, gloves
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis
03/14/2000CA2195213C Use of droloxifene for the treatment of cardiovascular diseases
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012504A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012481A2 Indazole derivatives with 5-ht2 receptor activity________________
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012070A1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
03/09/2000WO2000012069A1 Therapeutic formulation for administering tolterodine with controlled release
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO2000011952A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000CA2696878A1 Compositions and methods for treatment of mitochondrial diseases
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342109A1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341612A1 Indazole derivatives with 5-ht2 receptor activity
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983352A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983265A1 Endothelin receptor antagonists
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983076A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
03/08/2000CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action
03/08/2000CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/07/2000US6034246 Anticancer agent
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010604A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000WO2000010601A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010559A1 Inorgasmia treatment
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000DE19941248A1 New cetrorelix analogs containing N-substituted glycine derivatives useful as LHRH antagonists, e.g. for treating hormone-dependent tumors
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 562